Drug package
Latest Amicus Therapeutics, Inc. Patents:
Description
The broken lines depict environmental subject matter only and form no part of the claimed design.
Claims
The ornamental designs for a drug package, substantially as shown and described.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
Other references
D263559 | March 30, 1982 | Poore |
D339742 | September 28, 1993 | Walchek, Jr. |
D441192 | May 1, 2001 | Park |
D478810 | August 26, 2003 | Wilson |
D505320 | May 24, 2005 | Gattefosse |
D539166 | March 27, 2007 | Spencer |
D546198 | July 10, 2007 | Currie |
D599654 | September 8, 2009 | Kosaka |
D622158 | August 24, 2010 | Proulx |
D658069 | April 24, 2012 | Boyer |
D702116 | April 8, 2014 | Buchanan |
D723390 | March 3, 2015 | Eriksson |
D770303 | November 1, 2016 | Gelbaum |
D795083 | August 22, 2017 | Safiullin |
D806570 | January 2, 2018 | Gelbaum |
2015/164210 | October 2015 | WO |
- MWV introduces Shellpak Renew with Optilock. [online] Published on Dec. 23, 2014. Retrieved Mar. 8, 2018 from URL: https://www.businesswire.com/news/home/20130808005877/en/MWV-introduces-Shellpak%C2%AE-Renew-Optilock%E2%84%A2-technology-smallest.
- MWV introduces Shellpak Renew with Optilock. [online] Published on Dec. 23, 2014. Retrieved Mar. 8, 2018 from URL: https://www.businesswire.eom/news/home/20130808005877/en/MWV-introduces-Shellpak%C2%AE-Renew-Optilock%E2%84%A2-technology-smallest.
- “Amicus Therapeutics Announces European Commission Approval for Galafold™ (Migalastat) in Patients with Fabry Disease in European Union”, Amicus Therapeutics Press Release, May 31, 2016, 3 pages.
- File History for U.S. Appl. No. 29/605,763, 34 pages.
- Galafold 123 mg Packaging in German, May 30, 2016, 2 pages.
- NDA 208623 Accelerated Approval Letter and Labeling, Aug. 10, 2018, 40 pages.
Patent History
Patent number: D843850
Type: Grant
Filed: Nov 23, 2016
Date of Patent: Mar 26, 2019
Assignee: Amicus Therapeutics, Inc. (Cranbury, NJ)
Inventors: Jeffrey LoPrete (Cranbury, NJ), Muzammil Mustufa (Cranbury, NJ), Jayne Gershkowitz (Cranbury, NJ)
Primary Examiner: Vy N Koenig
Application Number: 29/585,388
Type: Grant
Filed: Nov 23, 2016
Date of Patent: Mar 26, 2019
Assignee: Amicus Therapeutics, Inc. (Cranbury, NJ)
Inventors: Jeffrey LoPrete (Cranbury, NJ), Muzammil Mustufa (Cranbury, NJ), Jayne Gershkowitz (Cranbury, NJ)
Primary Examiner: Vy N Koenig
Application Number: 29/585,388
Classifications
Current U.S. Class:
D9/732;
D9/756;
D9/432